Introduction
Ischemia-induced ventricular dysfunction has been shown to be associated with increased diastolic and systolic intracellular concentrations of free, ionized calcium (ICa2+I). The present study was designed to determine the effects of the Ca2+ antagonist nisoldipine on the relationship between [Ca2"I] and left ventricular contraction and relaxation during ischemia and reperfusion on a beat-to-beat basis. Nine isovolumic coronary-perfused ferret hearts were made globally ischemic for 3 min and reperfused for 10 min. Ischemia and reperfusion were repeated during perfusion with a buffer containing 10-8 M nisoldipine. From left ventricular developed pressure, time to peak pressure and time to 50% pressure decline were obtained. ICa2+I1 was determined with the bioluminescent protein aequorin.
Global ischemia caused a rapid decline in contractile func- 
Methods
The experimental preparation has been previously described in detail (2) . Nine male ferrets 10-14 wk old were anesthetized and heparinized.
The hearts were removed and Langendorif-perfused with a modified Krebs-Henseleit solution composed of (mM): NaCl 118, KCl 4.7, MgCl2 1.2, CaCl2 2, KH2PO4 1.2, NaHCO3 23, and dextrose 5.5. The solution was saturated with 95% 0J5% CO2 to adjust the pH to 7.4.
Perfusion flow was set to achieve a pressure of 80 mmHg measured with a transducer (model P23Db; Gould-Statham, Cleveland, OH). A thin latex balloon tied to the end of a polyethylene tube was inserted into the left ventricle (LV)' through the mitral valve and connected to the transducer to measure isovolumic pressure. The balloon volume was set to achieve an end-diastolic pressure of 8-15 mmHg. Thebesian venous return was drained from the LV via a tube placed in parallel with the LV catheter. The pulmonary artery was cannulated and drained. Each heart was paced at 1.7-2.0 Hz via a platinum wire inserted into the right ventricle through the right atrium.
In the present study, we applied our macroinjection method to the isolated, perfused whole heart preparation, as previously described in detail (2) . After a 20-min stabilization period, the coronary perfusate was replaced with a low Ca2' solution composed of (mM): NaCI 118, KCI 4.7, KH2PO4 1.2, MgCl2 5, NaHCO3 23, dextrose 20, and pyruvate 5. The pH was 7.30±0.02 when saturated by a gaseous mixture of 95% 0J5% CO2 at 200C. Within 3 min, the heart became completely quiescent and coronary resistance fell. The coronary perfusion rate was then reduced to 5-8 ml/min for maintenance of a perfusion pressure of 25-30 mmHg. Subsequently, the heart was temporarily raised out of the organ bath, and an aequorin-loading solution composed of aequorin 1.0 mg/ml, NaCl 154 mM, KCI 5.4 mM, MgCI2 1.0 mM, Hepes 12 mM, dextrose 11 mM, and EDTA 0.1 mM (pH 7.40±0.02), was injected into the interstitium of the epicardium, just beneath the epimysium, with a low-resistance glass micropipette. In toto, 3-541 ofthe aequorin-loading solution was injected within 3 min into a localized region of -3 mm in diam. After loading, the heart was repositioned in the concavity at the bottom ofthe organ bath and the aequorin-loaded region of the LV was directed toward the cathode of the photomultiplier tube. The Ca2" concentration ofthe coronary perfusate was slowly increased in a stepwise fashion every 15 min over the period of 1 h to prevent calcium paradox. When the Ca2' concentration in the perfusate reached 0.3 mM, the perfusion rate and the temperature were gradually increased over the course of 15 min to attain the levels present before loading. During this period, the heart showed an initiation of weak and sporadic contractions. After replacement ofcoronary perfusate by the standard solution at the previous perfusion rate at 30°C, the LV isovolumic pressure and coronary perfusion pressure recovered within 3 min, and a steady state was achieved within 20 min.
After aequorin loading and stabilization, the hearts were perfused with a non-recirculating buffer solution that passed through them only once before discard. The aequorin light signal, LV isovolumic pressure, and coronary perfusion pressure were recorded simultaneously on a strip chart recorder (Gould Inc. Instruments Div., Cleveland, OH) and magnetic tape recorder (Vetter, Petersburg, PA). Quantitation of calcium was performed in six of the studied hearts by the method of fractional luminescence (8) . In brief, this involves: (a) normalization of the aequorin light at each phase of the experiment by the amount of active aequorin in the preparation; and (b) conversion of the normalized light signal to a [Ca2+]i value by use of an in vitro calibration curve (2) .
Nisoldipine (gift of Dr. Alexander Scriabine, Miles Inc., West Haven, CT) was dissolved in polyethylene glycol 400 (PEG400) to produce a 2.58 x 10-3 M stock solution. Nisoldipine was added to the perfusion buffer to achieve a final concentration of 10-1 M. Previous studies have demonstrated that higher concentrations of the vehicle (PEG400) have no effect on cardiac function, high energy metabolites, or recovery from ischemia (9) . As a result ofnisoldipine's light sensitivity, the perfusion lines were covered with an opaque wrapping.
After control perfusion, the hearts were made globally ischemic for 3 min by clamping the perfusion line, and were then reperfused for 10 min. After 20 min ofperfusion with a buffer solution containing nisoldipine 10-8 M, global ischemia was repeated for 3 min, followed by 10 min of reperfusion. LV end-diastolic pressure, developed pressure (peak systolic pressure minus end-diastolic pressure), time to peak pressure, and time to 50% pressure decline were measured from LV pressure recordings. End-diastolic and end-systolic [Ca2l]i were determined from the aequorin light signal. Lactate production was measured in samples taken via the right ventricular drainage during 1 min before ischemia and during the first minute of reperfusion (Roche Analytical Instruments Inc., Nutley, NJ).
Observations before and after nisoldipine administration were compared statistically using analysis of variance. When an overall significance was observed, multiple comparisons were performed to determine which paired comparisons were significant. A value of P < 0.05 was considered significant. Data are expressed as mean±SD.
Results
Fig. 1 and Table I show the effects ofischemia and reperfusion in our preparations before and after the administration of nisoldipine. Before In the present study, repetitive periods of ischemia were used to determine the effects of nisoldipine on ischemic myocardium. The effects of the drug could mask delayed recovery after the control ischemic period. A previous study has shown that the mechanical changes and the amount oflactate production were virtually identical during two 3-min episodes of global ischemia followed by a 23-min recovery period (13 Effects ofnisoldipine on L Vfunction. The most important result of our study is that it provides direct quantitative evidence, on a beat-to-beat basis, that the calcium antagonist nisoldipine can ameliorate ischemia-induced abnormalities in
[Ca2+]i handling, an effect that correlates with improved myocardial function during early reperfusion. The results of our study concerning the effects of short periods ofglobal ischemia followed by reperfusion on LV isovolumic pressure development and indices of relaxation are similar to those previously reported (13) . Moreover, our results indicate a relatively greater effect of ischemia on the rate of isovolumic relaxation than developed pressure generation during the recovery period (13, 14) .
Previous studies have suggested that calcium antagonists modify the functional changes that occur with ischemia and reperfusion. Watts et al. (6) reported that verapamil (7.5 X 1o-8 M-2 X 10-6 M) improves the functional recovery and enhances ATP production of rat hearts subjected to 27 min of global ischemia followed by 30 min of reperfusion. The same investigators reported similar beneficial effects of nifedipine (7.5 X 10-7 M) and diltiazem (7.5 X 10-6 M) in a related study (1 1 10-7 M permitted nearly complete recovery of relaxation following low flow ischemia in rabbits (20) . Our results (Table I) regarding the effects of nisoldipine on left ventricular relaxation, are consistent with this report. It should be noted, however, that nisoldipine decreased left ventricular developed pressure, produced a rise in end-diastolic pressure at baseline, and produced further slight changes during reperfusion. We believe that these changes, which were associated with decreased systolic [Ca2+]i, are consistent with the negative inotropic actions of the drug (6, 15, 18) . Vasodilatation produced by nisoldipine probably accounts for the increase in end-diastolic pressure (21) (25) . In a study with '9F NMR, Steenbergen et al. (7) reported that diltiazem (0.9 gM) attenuated the ischemia-induced rise in [Ca2+]i in hearts loaded with 5F-BAPTA. The results of the present study lead to the same conclusion by a different experimental approach with regard to nisoldipine, the second generation calcium antagonist. 
